Advancing Oral Treatment Options for People with Eosinophillic Esophagitis (EoE)
If you have been diagnosed with EoE or suspect that your symptoms may be due to EoE, and are interested in participating in a clinical trial assessing an investigational treatment option, scroll down for more information
If you have difficulty swallowing or if food going down feels uncomfortable, you may have EoE. If you are diagnosed with EoE, you may be able to participate in a clinical trial called FLUTE 3 (FLUTicasone propionate in Eosinophilic esophagitis) assessing APT-1011. APT-1011 is an investigational tablet that is placed on the back of the tongue once a day at bedtime. After the tablet melts (in less than 30 seconds) it is swallowed to coat the esophagus. The clinical trial FLUTE 3, will evaluate if APT-1011 treats the inflammation causing your EoE symptoms.
Additional criteria will need to be met and will be discussed with a Healthcare Practitioner (HCP) at the clinical trial site. These additional criteria will be discussed with you prior to enrollment in this clinical trial and can also be found at clinicaltrials.gov at https://clinicaltrials.gov/ct2/show/NCT05634746.
What are the benefits of participating in a clinical trial?
Participation in this clinical trial means that you are helping the development of an investigational treatment for EoE. If the results of this trial indicate that the investigational treatment is beneficial, it may then be approved by the United States Food and Drug Administration for patients with EoE.
Frequently Asked Questions
Clinical trials evaluate the safety and effectiveness of treatments before the FDA approves them for general use in the population. All participants in a clinical trial must meet established enrollment criteria and agree to follow the clinical trial schedule and procedures. Clinical trials are run through medical centers trained to guide participants through the clinical trial process.
You will be reimbursed for your time, and some travel expenses. You will not be required to pay for treatments and procedures related to the conduct of the trial. These details will be reviewed with you prior to your agreement to participate.
You may experience relief of your EoE symptoms as a result of your participation in this clinical trial however, there is no guarantee. Your participation will help to inform the overall evaluation of the safety and effectiveness of this investigational drug.
See below for a map of our current trial sites. We will update the map as sites are added, but you may or may not see a trial location in your zip code. By completing the form below or calling 1-833-4FLUTE3 a member of the Ellodi Pharma team can take your information and assist you in connecting with a trial site.